300 related articles for article (PubMed ID: 36051242)
1. Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer.
Ying HZ; Xie W; Wang MC; He JQ; Zhang HH; Yu CH
Front Cell Infect Microbiol; 2022; 12():969526. PubMed ID: 36051242
[TBL] [Abstract][Full Text] [Related]
2. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
3. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
[TBL] [Abstract][Full Text] [Related]
4. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy.
Yixia Y; Sripetchwandee J; Chattipakorn N; Chattipakorn SC
Anaerobe; 2021 Apr; 68():102361. PubMed ID: 33781900
[TBL] [Abstract][Full Text] [Related]
5. The role of intestinal microbiota in the pathogenesis of colorectal carcinoma.
Kuzma J; Chmelař D; Hájek M; Lochmanová A; Čižnár I; Rozložník M; Klugar M
Folia Microbiol (Praha); 2020 Feb; 65(1):17-24. PubMed ID: 31001762
[TBL] [Abstract][Full Text] [Related]
6. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
[TBL] [Abstract][Full Text] [Related]
8. Metformin effect on gut microbiota: insights for HIV-related inflammation.
Ouyang J; Isnard S; Lin J; Fombuena B; Marette A; Routy B; Chen Y; Routy JP
AIDS Res Ther; 2020 Mar; 17(1):10. PubMed ID: 32156291
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
[TBL] [Abstract][Full Text] [Related]
10. Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies.
Illescas O; Rodríguez-Sosa M; Gariboldi M
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209683
[TBL] [Abstract][Full Text] [Related]
11. Berberine: Potential preventive and therapeutic strategies for human colorectal cancer.
Feng Y; Lu J; Jiang J; Wang M; Guo K; Lin S
Cell Biochem Funct; 2024 Jun; 42(4):e4033. PubMed ID: 38742849
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
Kang Y; Pan W; Cai Y
Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
[TBL] [Abstract][Full Text] [Related]
13. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
Taghinezhad-S S; Mohseni AH; Fu X
J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
[TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota and colorectal cancer: a new aspect of research.
Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
Fan X; Jin Y; Chen G; Ma X; Zhang L
Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
[TBL] [Abstract][Full Text] [Related]
16. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts.
Zhang Z; Shao S; Zhang Y; Jia R; Hu X; Liu H; Sun M; Zhang B; Li Q; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110916. PubMed ID: 33113425
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.
Pan S; Guo Y; Hong F; Xu P; Zhai Y
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166281. PubMed ID: 34610472
[TBL] [Abstract][Full Text] [Related]
18. Herbal medicine and its impact on the gut microbiota in colorectal cancer.
Bu F; Tu Y; Wan Z; Tu S
Front Cell Infect Microbiol; 2023; 13():1096008. PubMed ID: 37469598
[TBL] [Abstract][Full Text] [Related]
19. Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies.
Ha S; Zhang X; Yu J
Chin Med J (Engl); 2024 Jan; 137(1):8-20. PubMed ID: 38031348
[TBL] [Abstract][Full Text] [Related]
20. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
